Thyroid Cancer: What Are the Latest Advances in Treatment?
-
By
-
September 29, 2026
-
6 min
By
September 29, 2026
Standardized preprocessing, multicenter datasets, external validation, and interpretable models may matter more than further gains in classification accuracy
September 30, 2026
Trametinib and dabrafenib increased TSHR expression and improved the activity of CAR T cells in a patient-derived model of anaplastic thyroid cancer
September 24, 2026